2

Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: A simulation study

*BMC Medical Research Methodology* 2018; 18:105

Group sequential crossover trial designs with strong control of the familywise error rate

*Sequential Analysis* 2018; 37(2):174-203

Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity

*Nature Communications* 2018; 9:3927

A novel nano-iron supplement to safely combat iron deficiency and anaemia in young children: The IHAT-GUT double-blind, randomised, placebo-controlled trial protocol

*Gates Open Research* 2018; 2:48

Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom

*Alimentary Pharmacology & Therapeutics* 2018; 48(9):951-960

Detecting responses to treatment with fenofibrate in pedigrees

*BMC Genetics* 2018; 19:64

Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits

*Nature Genetics* 2018; 50:1412–1425

Using penalized regression to predict phenotype from SNP data

*BMC Proceedings* 2018; 12(9):38

Blinded and unblinded sample size reestimation in crossover trials balanced for period

*Biometrical Journal* 2018; 60(5):917-933

Blinded and unblinded sample size reestimation procedures for stepped-wedge cluster randomized trials

*Biometrical Journal* 2018; 60(5):903-916